Simpson EL, Guttman-Yassky E, Eichenfield LF, Boguniewicz M, et al. Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition. Allergy 2023 Jul 16. doi: 10.1111/all.15811.
PMID: 37455359